Pamela Freda
Professor of Medicine at the Columbia University Medical Center · New York Presbyterian Hospital
Credentials: · · ·
History
- 1991–1993
THE KINGS COLLEGE
- 1988–1991
Internal Medicine
Research
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
New England Journal of Medicine · 2000 · 629 citations
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
The Lancet · 2001 · 473 citations
Pituitary incidentaloma: an endocrine society clinical practice guideline
The Journal of Clinical Endocrinology & Metabolism · 2011 · First of 8 authors · 410 citations
27 papers
26 papers
24 papers
11 papers
- EG
9 papers · 1 as a fellow
9 papers
9 papers
- AK
5 papers
Grants
- 2023–2028
Central Mediation of Growth Hormone Effects in Humans
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.4M · Columbia University Health Sciences
- 2017–2023
New Approaches to the Evaluation and Treatment of Acromegaly
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.3M · Columbia University Health Sciences
- 2003–2017
New Approaches to the Evaluation and Treatment of Acromegaly
National Institute of Diabetes and Digestive and Kidney Diseases · R56
Contact PI · $228.8K · Columbia University Health Sciences
- 2010–2017
Prospective Study of Clinically Non-Functioning Pituitary Adenomas
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.7M · Columbia University Health Sciences
Clinical trials
- 2019–2023
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Principal investigator · Completed · Phase 3
Camurus AB
- 2019–2020
Adipose Tissue and Serum Inflammation in GH Deficiency
Principal investigator · Completed
Columbia University
- 2018–2025
Body Composition and Adipose Tissue in HIV
Principal investigator · Terminated · Phase 4
Columbia University
- 2017–2025
Adipose Tissue and Circulating Markers of Inflammation in GH Deficiency and Changes With GH Therapy
Principal investigator · Completed
Columbia University